# Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

> **NCT01870674** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 127 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** YH12852
- **DRUG:** Prucalopride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01870674
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2015-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01870674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01870674, "Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01870674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*